Research and development expenditure grew dramatically in Q4 of 2020—by nearly 12% compared with Q3. However, just three sectors accounted for most of that growth: pharmaceuticals, biotechnology & medical research, and software & IT services.
Excluding these three sectors, R&D expenditure still increased, but at a more modest pace of around 3.5%.